BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:51 PM
 | 
Mar 02, 2010
 |  BC Extra  |  Company News

FDA approves Exalgo

CombinatoRx Inc. (NASDAQ:CRXX) gained $0.37 (33%) to $1.48 on Tuesday after FDA approved Exalgo hydromorphone to manage moderate to severe pain...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >